Metabolomics Workbench : NIH Data Repository

MB Sample ID: SA346797

Local Sample ID:	DS2-039-030
Subject ID:	SU003304
Subject Type:	Mammal
Subject Species:	Mus musculus
Gender:	Not applicable

Select appropriate tab below to view additional metadata details:

Treatment:

Treatment ID:	TR003313
Treatment Summary:	All animal procedures were carried out in accordance with the IACUC-approved protocol of Cincinnati Children’s Hospital Medical Center. Animals were monitored daily by Veterinary Services. For subcutaneous tumor implantation, 1x10^6 B16F10 cells were mixed with matrigel 1:1 and implanted subcutaneously into NOD-SCID IL2Rgnull or C57BL/6 mice, respectively. CAY10566 was suspended in 0.5% Methyl Cellulose in water with 0.2% Tween 80 at 9 parts per 1 part DMSO stock. CAY10566 was administered at 30mg/kg via oral gavage, twice daily, with a drug holiday during the weekends. Treatment began three days after tumor cell implantation (bilateral tumors in n=4 per group). Mice were euthanized17 days after tumor cell injection/14 days after the start of treatment.

Treatment ID:

TR003313

Treatment Summary:

All animal procedures were carried out in accordance with the IACUC-approved protocol of Cincinnati Children’s Hospital Medical Center. Animals were monitored daily by Veterinary Services. For subcutaneous tumor implantation, 1x10^6 B16F10 cells were mixed with matrigel 1:1 and implanted subcutaneously into NOD-SCID IL2Rgnull or C57BL/6 mice, respectively. CAY10566 was suspended in 0.5% Methyl Cellulose in water with 0.2% Tween 80 at 9 parts per 1 part DMSO stock. CAY10566 was administered at 30mg/kg via oral gavage, twice daily, with a drug holiday during the weekends. Treatment began three days after tumor cell implantation (bilateral tumors in n=4 per group). Mice were euthanized17 days after tumor cell injection/14 days after the start of treatment.